Wednesday, 31 October 2012

Novo Nordisk raises year view after Q3 beats fcasts

COPENHAGEN (Reuters) - Denmark's Novo Nordisk lifted third-quarter core profit by 40 percent and above expectations on the back of strong sales of diabetes drug Victoza and modern insulins.

via Reuters: Health News Read More Here..

No comments:

Post a Comment